Remedium Lifecare Faces Intense Selling Pressure Amidst Significant Price Declines
Remedium Lifecare Ltd is experiencing intense selling pressure, with a 41.08% decline over the past 13 days and a 69.50% drop year-to-date. The stock has reached a new all-time low, significantly underperforming the Sensex amid broader market challenges affecting the trading and distribution sector.
Remedium Lifecare Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past 13 days, resulting in a staggering loss of 41.08% during this period. Today, the stock fell by 4.39%, significantly underperforming the Sensex, which declined by only 1.13%.In the past week, Remedium Lifecare has dropped 19.85%, while the Sensex saw a modest decrease of 1.73%. Over the last month, the stock has plummeted by 35.88%, contrasting sharply with the Sensex's slight decline of 0.47%. Year-to-date, Remedium Lifecare has lost 69.50%, compared to the Sensex's gain of 3.36%. The stock has now reached a new 52-week and all-time low of Rs. 1.09.
The company's performance metrics indicate it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further highlighting the ongoing selling trend. Factors contributing to this selling pressure may include broader market conditions and specific challenges faced by the trading and distribution sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
